Parallax Volatility Advisers
SRRA

Parallax Volatility Advisers’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Parallax Volatility Advisers’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-169
Closed -$20K – 3868
2018
Q2 		$20K Hold
169
– – ﹤0.01% 1690
2018
Q1 		$14K Hold
169
– – ﹤0.01% 1779
2017
Q4 		$25K Hold
169
– – ﹤0.01% 3594
2017
Q3 		$10K Buy
+169
New +$9.91K ﹤0.01% 1744

Other funds holding SRRA

FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Parallax Volatility Advisers's SRRA Position: Q3 2018 in Review

Parallax Volatility Advisers sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2018, closing a stake of 169 shares — an estimated $20K sold.

Parallax Volatility Advisers first reported a position in SRRA in Q3 2017 and held it in 4 quarters. The position peaked at $25K in Q4 2017. 60 funds tracked by Wall St. Rank hold SRRA as of Q3 2018.

  • Parallax Volatility Advisers reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
  • Parallax Volatility Advisers sold 169 Sierra Oncology, Inc. Common Stock shares in Q3 2018, an estimated $20K.
  • Parallax Volatility Advisers first reported a position in Sierra Oncology, Inc. Common Stock in Q3 2017 and held it in 4 quarters.
  • Parallax Volatility Advisers's Sierra Oncology, Inc. Common Stock position peaked at $25K in Q4 2017.
  • 60 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2018.

Based on Parallax Volatility Advisers's 13F filing for Q3 2018, filed 14 Nov 2018.